Pipequaline hydrochloride;80221-58-5
|
鹽酸哌夸林
|
80221-58-5
|
RGFP966
|
RGFP966
|
1357389-11-7
|
JD5037
|
JD-5037
|
1392116-14-1
|
SBC-1107326(b)
|
化合物SBC-110736
|
1629166-02-4
|
XL335
|
3-(3,4-二氟苯甲?;?-1,2,3,6-四氫-1,1-二甲基氮雜卓[4,5-B]吲哚-5-甲酸 1-甲基乙基酯
|
629664-81-9
|
RQ00203078
|
4-(N-(3-氯-5-(三氟甲基)吡啶-2-基)-N-(4-(三氟甲氧基)芐基)氨基磺?;?苯甲酸
|
1254205-52-1
|
GIBH-130
|
GIBH-130
|
1252608-59-5
|
Pocapavir(SCH-48973; V-073)
|
SCH 48973
|
146949-21-5
|
TUG-891
|
TUG 891
|
1374516-07-0
|
TM5441
|
CS-2510
|
1190221-43-2
|
CaCCinh-A01
|
CACCINH-A01
|
407587-33-1
|
APD597
|
APD597
|
897732-93-3
|
B02
|
RAD51 INHIBITOR B02
|
1290541-46-6
|
GF109203X
|
GF109203X
|
133052-90-1
|
SR4370
|
SR-4370
|
1816294-67-3
|
GW9508
|
885101-89-3(GW9508)
|
885101-89-3
|
CP671305
|
CS-2886
|
445295-04-5
|
SR17018
|
SR17018
|
2134602-45-0
|
AZD1080
|
AZD1080
|
612487-72-6
|
triapine
|
(3-氨基吡啶-2-基)亞甲基氨基]硫脲
|
143621-35-6
|
Porcupine-IN-1
|
Porcupine-IN-1
|
2036044-77-4
|
HLCL-61 HCL
|
HLCL-61 鹽酸鹽
|
1158279-20-9
|
AZ32
|
AZ32
|
2288709-96-4
|
SB-505124
|
SB-505124
|
694433-59-5
|
Benzamide, N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-4-chloro-, hydrochloride (1:1)
|
PNU-282987
|
123464-89-1
|
VU 0364770
|
VU 0364770
|
61350-00-3
|
SPHINX31
|
CS-2837
|
1818389-84-2
|
BIBF-0775
|
BIBF0775
|
334951-90-5
|
AZ304
|
AZ304
|
942507-42-8
|
N6022
|
N6022
|
1208315-24-5
|
AL 082D06
|
AL 082D06游離態(tài)
|
256925-03-8
|
UAMC-3203
|
UAMC-3203
|
2271358-64-4
|
RGX-104(HCl)
|
RGX-104 HCl
|
610318-03-1
|
F-15599
|
635323-95-4
|
635323-95-4
|
4-(4-(Benzyloxy)benzyl)piperidine hydrochloride
|
Pyrrolo[1,2-a]quinoxalin-4(5H)-one,5-[3-[4-(4-chlorophenyl)-1-piperidinyl]propyl]-
|
1380392-05-1
|
UAMC3203.HCL
|
UAMC-3203 HYDROCHLORIDE
|
2271358-65-5
|
TAK-063
|
1-(2-氟-4-(1H-吡唑-1-基)苯基)-5-甲氧基-3-(1-苯基-1H-吡唑-5-基)噠嗪-4(1H)-酮
|
1238697-26-1
|
Radiprodil
|
RADIPRODIL
|
496054-87-6
|
Enpp-1-IN-1
|
Enpp-1-IN-1
|
2289728-58-9
|
N-(2-BENZO[1,3]DIOXOL-5-YL-ETHYL)-2-(4-METHYL-BENZYL)-SUCCINAMIC ACID
|
N-(2-BENZO[1,3]DIOXOL-5-YL-ETHYL)-2-(4-METHYL-BENZYL)-SUCCINAMIC ACID
|
332849-40-8
|
CGP71683AHCl
|
N-[[反式-4-[[(4-氨基-2-喹唑啉基)氨基]甲基]環(huán)己基]甲基]-1-萘磺酰胺鹽酸鹽
|
192322-50-2
|
2-Piperazinone, 1-methyl-3-[2-(4-methylphenyl)-2-oxoethylidene]-
|
(3Z)-1-甲基-3-[2-(4-甲基苯基)-2-羰基-亞乙基]哌嗪-2-酮
|
178408-16-7
|
SB525334
|
6-[2-(1,1-二甲基乙基)-5-(6-甲基-2-吡啶基)-1H-咪唑-4-基]喹喔啉
|
356559-20-1
|
SERALUTINIB
|
3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl-
|
1619931-27-9
|
Merafloxacin
|
CI 934
|
91188-00-0
|
CK1-IN-1
|
CK1-IN-1
|
1784751-20-7
|
AMG487
|
AMG 487
|
473719-41-4
|
Pizuglanstat
|
化合物PIZUGLANSTAT
|
1244967-98-3
|
MS402
|
MS-402
|
1672684-68-2
|
PF-4708671
|
PF-4708671
|
1255517-76-0
|
PD169316
|
4-[4-(4-氟苯基)-2-(4-硝基苯基)-1H-咪唑-5-基]吡啶
|
152121-53-4
|
Ro 31-8220 mesylate
|
RO-31-8220
|
138489-18-6
|
Adezmapimod
|
4-(4-氟苯基)-2-(4-甲基亞磺?;交?-5-(4-吡啶基)-1H-咪唑
|
152121-47-6
|
LMPTP INHIBITOR 1 dihydrochloride
|
LMPTP INHIBITOR 1 dihydrochloride
|
2310135-46-5
|
SAPA-1j
|
SMS1-IN-1
|
1807943-38-9
|
MRGPRX1 agonist 1
|
MRGPRX1 agonist 1
|
2377379-39-8
|
Menin-MLL inhibitor 20
|
Carbamic acid, N-[(3R)-1-[[2-[[[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]amino]carbonyl]-4-pyridinyl]methyl]-3-piperidinyl]-, 1,1-dimethylethyl ester
|
2448173-47-3
|
LY2090314
|
LY 2090314
|
603288-22-8
|
REMODELIN.HBR
|
REMODELIN
|
1622921-15-6
|
GR 125,743
|
化合物GR 125743
|
148547-33-5
|
JNJ-18038683
|
化合物JNJ-18038683
|
851376-05-1
|
Aumitin
|
AUMITIN
|
946293-78-3
|
ROCK inhibitor-2
|
ROCK inhibitor-2
|
1127308-52-4
|
LY2584702 Tosylate
|
LY2584702 TOSYLATE
|
1082949-68-5
|
PS210
|
PS 210
|
1221962-86-2
|
N-(Pyridin-3-yl)-4-(3-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzyl)piperidine-1-carboxamide
|
PF 3845
|
1196109-52-0
|
AT7519
|
4-[(2,6-二氯芐基)氨基]-N-4-哌啶1H-吡唑-3-羧胺
|
844442-38-2
|
TM 5275
|
CS-2524
|
1103926-82-4
|
piperidin-1-yl(1-m-tolyl-1H-indazol-6-yl)methanone
|
piperidin-1-yl(1-m-tolyl-1H-indazol-6-yl)methanone
|
451496-96-1
|
SKF96365HCl
|
1-[2-(4-甲氧基)-2-[3-(4-甲氧基苯基)丙氧基]乙基]咪唑
|
130495-35-1
|
MLS1547
|
5-CHLORO-7-[[4-(2-PYRIDINYL)-1-PIPERAZINYL]METHYL]-8-QUINOLINOL
|
315698-36-3
|
TUG-469
|
TUG-469
|
1236109-67-3
|
PDGFR Tyrosine Kinase Inhibitor III
|
PDGFR酪氨酸激酶抑制劑III
|
205254-94-0
|
Enpp-1-IN-14
|
化合物ENPP-1-IN-14
|
2687222-59-7
|
CCR8 antagonist 1
|
化合物CCR8 ANTAGONIST 1
|
723304-76-5
|
W-9 hydrochloride
|
N-(6-氨基己基)-5-氯-2-萘磺酰胺 鹽酸鹽
|
69762-85-2
|
CP-289503
|
化合物CP-289
|
1349637-14-4
|
Todralazine hydrochloride
|
鹽酸托屈嗪
|
3778-76-5
|
Benzenesulfonamide, 2-amino-N-8-quinolinyl-
|
16082-64-7
|
16082-64-7
|
LRE1-RU-0204277
|
化合物 T15787
|
1252362-53-0
|
ML264
|
(2E)-3-(3-氯苯基)-N-[2-[甲基(四氫-1,1-二氧代-2H-噻喃-4-基)氨基]-2-氧代乙基]-2-丙烯酰胺
|
1550008-55-3
|
LY2584702
|
LY-2584702
|
1082949-67-4
|
RO462005
|
RO462005
|
150725-87-4
|
OTSSP167.HCl
|
OTSSP 167 鹽酸鹽
|
1431698-10-0
|
CarbaMiMidothioic acid, 3-cyanopropyl ester, hydrochloride (1
|
KEVETRIN, NSC 525990
|
66592-89-0
|
ZM-306416(CB 676475)
|
N-(4-氯-2-氟苯基)-6,7-二甲氧基-4-喹唑啉胺
|
690206-97-4
|
4-Quinazolinamine, N-(3-bromophenyl)-6,7-dimethoxy-, hydrochloride (1:1)
|
PD153035 HCl
|
183322-45-4
|
IWR-1
|
IWR-1
|
1127442-82-3
|
CAIX Inhibitor S4
|
CAIX Inhibitor S4
|
1330061-67-0
|
hMAO-B-IN-4
|
化合物HMAO-B-IN-4
|
1666119-75-0
|
WAY-299838
|
WAY-299838
|
333357-56-5
|
p38α inhibitor 3
|
WAY-313218
|
260428-69-1
|
Tie2 kinase inhibitor 1
|
Tie2 kinase inhibitor
|
948557-43-5
|
SK 137647
|
4-甲氧基-N-(2,4,6-三甲基苯)苯磺酰胺
|
349085-82-1
|
MLN120B.2 HCl
|
MLN120B DIHYDROCHLORIDE
|
1782573-78-7
|
TT01001
|
1-Piperidinecarboxylic acid, 4-[[[(3,5-dichlorophenyl)amino]thioxomethyl]amino]-, ethyl ester
|
1022367-69-6
|
7-[(2,3-Dichlorophenyl)(pyridin-2-ylamino)methyl]quinolin-8-ol
|
7-((2,3-二氯苯基)(吡啶-2-基氨基)甲基)喹啉-8-醇
|
352693-80-2
|
H7
|
1-(5-異喹啉磺?;?-2-甲基哌嗪
|
84477-87-2
|
H7.2HCL
|
H-7雙鹽酸鹽
|
108930-17-2
|
4-AMINO-N-(2-PHENYLETHYL)BENZENESULFONAMIDE
|
C7280948
|
587850-67-7
|